Observational studyJournal of neurology2024

Quality of life and tolerability of B-cell directed therapy of multiple sclerosis with ofatumumab in a patient-centered real-world observational study.

Anna-Sophia Karl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.